NLRP3 and Hepatic fibrosis: To further determine whether elevated GCDCA can cause liver fibrosis in vivo and the role of NLRP3 in the progression of liver fibrosis, we used GCDCA gavage and CCl4 intraperitoneal injection intervention, and the results showed that both of them could induce liver fibrosis in mice.